Stifel Financial
NVLN

Stifel Financial’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Stifel Financial’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,000
Closed -$7K – 3154
2019
Q3 		$7K Hold
10,000
– – ﹤0.01% 2847
2019
Q2 		$8K Hold
10,000
– – ﹤0.01% 2953
2019
Q1 		$12K Hold
10,000
– – ﹤0.01% 2784
2018
Q4 		$8K Hold
10,000
– – ﹤0.01% 2655
2018
Q3 		$30K Hold
10,000
– – ﹤0.01% 2718
2018
Q2 		$37K Hold
10,000
– – ﹤0.01% 2676
2018
Q1 		$35K Hold
10,000
– – ﹤0.01% 2647
2017
Q4 		$31K Hold
10,000
– – ﹤0.01% 2607
2017
Q3 		$70K Hold
10,000
– – ﹤0.01% 2499
2017
Q2 		$92K Hold
10,000
– – ﹤0.01% 2461
2017
Q1 		$107K Buy
+10,000
New +$102K ﹤0.01% 2424

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return